Phase 2 double-blind RCT of 132 patients having radiotherapy for head and neck cancer: fullerene cream reduced grade 2 or worse acute radiation dermatitis vs trolamine (34.8% vs 83.3%).
RCTn = 132
Liu et al. Fullerene for Reducing Acute Radiation Dermatitis in Patients Undergoing Radiotherapy for Head and Neck Cancer: A Phase II, Double-Blind, Randomized Controlled Trial